Patient perceptions and knowledge of corticosteroid injections: A cross-sectional survey study
PLOS One · 18.03.2026 · 21 (3) · e0344201
DOI: 10.1371/journal.pone.0344201 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift PLOS One, online erschienen am 18.03.2026. Verfasst von Juliet Chung und 6 weiteren Autor:innen. Beteiligte Einrichtung: Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, United States of America. Hauptthemen laut MEDLINE: Health Knowledge, Attitudes, Practice, Adrenal Cortex Hormones, Cortisone. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Rothman Opioid Foundation.
Abstract (Originalsprache)
Introduction
Although cortisone injections are commonly used, patient understanding of cortisone is variable and often affected by misconceptions. This study explores patient perspectives, identifies misconceptions, and emphasizes the importance of improved patient education to enhance patient-centered care.
Methods
A cross-sectional survey study was conducted from April to August 2024 among patients aged 18 and older presenting to an orthopedic physicians’ office. Patients completed a novel anonymous questionnaire designed to assess their knowledge and perceptions of cortisone injections. A total of 246 patients participated, with responses collected electronically via SurveyMonkey.
Results
Among 246 respondents, individuals with history of prior cortisone infections were significantly more likely to correctly identify its anti-inflammatory role (p < 0.05). Overall, 96% of respondents reported awareness of cortisone injections. However, many learned from personal connections rather than healthcare professionals as their primary source of information Most respondents (87%) reported receiving satisfactory explanations from their physicians, while 13% reported inadequate communication. A majority indicated willingness to receive cortisone injections if clinically indicated (84%). Despite this,concerns regarding safety persist, with 37% associating safety with dosage and injection frequency, and 15% reporting uncertainty about potential risks.
Conclusion
Misconceptions regarding cortisone injections remain prevalent, highlighting gaps in patient understanding. Although most patients recognize the anti-inflammatory effects of cortisone, knowledge deficits persist regarding safe dosing parameters and potential risks. Improved communication between healthcare providers and patients about cortisone’s mechanism of action and safety profile may support more informed clinical decision-making and outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, United States of America.
- Rothman Orthopaedic Institute at Thomas Jefferson University, Philadelphia, Pennsylvania, United States of America.
- University Texas at Austin, Austin, Texas, United States of America.
- Drexel University College of Medicine, Philadelphia, Pennsylvania, United States of America.
ORCID-Profile: Juliet Chung, Sina Ramtin, Philip Koehler, Brian Hozack
Förderung
- Rothman Opioid Foundation
Zitieren
APA
Chung, J., Ramtin, S., Koehler, P., Stache, S., Langman, C., Hozack, B., & Ilyas, A. M. (2026). Patient perceptions and knowledge of corticosteroid injections: A cross-sectional survey study. PLOS One, 21(3), e0344201. https://doi.org/10.1371/journal.pone.0344201
Vancouver
Chung J, Ramtin S, Koehler P, Stache S, Langman C, Hozack B, et al. Patient perceptions and knowledge of corticosteroid injections: A cross-sectional survey study. PLOS One. 2026;21(3):e0344201. doi:10.1371/journal.pone.0344201
BibTeX
@article{Chung2026,
author = {Chung, Juliet and Ramtin, Sina and Koehler, Philip and Stache, Stephen and Langman, Charles and Hozack, Brian and Ilyas, Asif M},
title = {Patient perceptions and knowledge of corticosteroid injections: A cross-sectional survey study},
journal = {PLOS One},
year = {2026},
volume = {21},
number = {3},
pages = {e0344201},
doi = {10.1371/journal.pone.0344201}
}
EUVIMED